Soni, Navneet Omprakash published the artcileTargeting LTB4 -BLT1 – in diabetic nephropathy?, Category: amides-buliding-blocks, the publication is World Journal of Pharmacy and Pharmaceutical Sciences (2017), 6(9), 312-315, database is CAplus.
A review. Lipid mediators play important role in renal injury many of lipid mediators are expressed and up regulated in response to toxins, drugs and in metabolic disorder. Lipid mediators also play role in vascular complication. So new intervention target can be thought by targeting the mediators Diabetic complication can be reduced unfortunately very few study are available to test the hypothesis and come to conclusion. But from all available study reports one can say targeting lipid mediators have future scope as well as limitation.
World Journal of Pharmacy and Pharmaceutical Sciences published new progress about 321673-30-7. 321673-30-7 belongs to amides-buliding-blocks, auxiliary class Immunology/Inflammation,Scavenger receptor, name is [(2-Hexylcyclopentylidene)amino]thiourea, and the molecular formula is C14H14, Category: amides-buliding-blocks.
Referemce:
https://en.wikipedia.org/wiki/Amide,
Amide – an overview | ScienceDirect Topics